Butz K，Shababeddin L，Geisen C，et al. Functional P53 protein in human papillomavirus-positive cancer cells[J]. Oncogene，1995，10:927-936？？
[2]
Liang XH，Mungal S，Ayscue A, et al？bcl-2 protooncogene expression in ce rvi cal carcinoma cell lines containing inactive P53[J].J Cell Biochem，1995，57( 3):509-521？？
[3]
Cher L，Chew K，Rosenau W，et al. Cellular proliferation in prostatic ad eno carcinoma as assessed by bromod-eoxyuridine up take and Ki67 and PCNA expression [J].Prostate，1995，26:8-7.？
Momand J Zambetti GP？MDM-2:“Big brother” of p53[J].J Cell Biochem ，1997，64:343-352？？
[9]
Hockenberg D，Nunez G，Milliman C, et al？Bcl-2 is an inner mitochondria lmembrane protein that blocks programmed cell death[J].Nature，1990，348:334？ ？
[10]
Graninger WB？SetoM？Boutain B，et al？Expression of Bcl-2 Ig fusion tran scriptscripts in nomal and neoplastic cells[J]. Clinic Invers，1987，80:1512 ？？
[11]
Poldowaki W，Van L Anschot JJ，Ten Kate FJ，et al. The value of P53，and K i67 as markers for tumor progression in the Barret's sysplasia carcinoma sepuenc e[J].Surg Oncol，1995，4:163-171？？
[12]
Liu SC，Edwand RSMargie LC，et al. Markers of cell proliferation in norm al epithelia and dysplastic leukoplakias od rhe oral cavity[J].Cancer Epidemiol Biom Prevetion，1998，7:597-603？〖ZK)〗？
[13]
Klala P.Signifiance of uitric oxide in carcinogenesis tumor progr ession and cancer theropy[J].Cancer Metast Rev，1998，17:1-6？？
[14]
Charpin C，Dicare MJ，Barbeau B，et al？Monoclonal 3c6f9 distribution in h uman breast carcinomas；Image cytometry of immunocy to the medical asseys[J]. Med Oncol Tumor Tharma Cother，1991，8(4)：243-251？？
